NCT03741010View on ClinicalTrials.gov

Belviq Tablet® Post Marketing Surveillance Protocol

UnknownOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

February 2, 2015

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Weight Loss
Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT03741010 - Belviq Tablet® Post Marketing Surveillance Protocol | Biotech Hunter | Biotech Hunter